Amylyx Pharmaceuticals (AMLX) Payables (2021 - 2026)
Amylyx Pharmaceuticals (AMLX) posted Payables of $5.53 million for Q2 2026, up 68.0% from $3.29 million a year earlier and up 56.8% from the prior quarter.
Powered by 
Analysis
Amylyx Pharmaceuticals (AMLX) Payables (2021 - 2026) Analysis & Trends
At the end of FY2025, Amylyx Pharmaceuticals' Payables came in at $3.52 million, up 19.7% from FY2024.
- Annual Payables shows a four-year compound annual growth rate of -5.3% (FY2021 to FY2025).
- In prior years, Amylyx Pharmaceuticals' Payables was $2.94 million in FY2024 (-86.7%), $22.06 million in FY2023 (+252.6%), $6.26 million in FY2022 (+43.1%) and $4.37 million in FY2021.
- The Q2 2026 figure stands as the highest quarterly Payables since Q1 2024.
- On a year-over-year basis, Payables increased in three of the last eight quarters, with growth averaging 5.7%.
- The strongest year-over-year quarter for Payables in the past five years was Q3 2025, with growth of 259.0%; the weakest was Q4 2024, with a decline of 86.7%.
- According to Business Quant data, Payables for the three prior quarters was $3.53 million (Q1 2026), $3.52 million (Q4 2025) and $5.34 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Amylyx Pharmaceuticals | 3.24 Bn | 2.05 Bn | - | 5.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.53 Mn |
| Mar 31, 2026 | 3.53 Mn |
| Dec 31, 2025 | 3.52 Mn |
| Sep 30, 2025 | 5.34 Mn |
| Jun 30, 2025 | 3.29 Mn |
| Mar 31, 2025 | 4.81 Mn |
| Dec 31, 2024 | 2.94 Mn |
| Sep 30, 2024 | 1.49 Mn |
| Jun 30, 2024 | 4.96 Mn |
| Mar 31, 2024 | 21.45 Mn |
| Dec 31, 2023 | 22.06 Mn |
| Sep 30, 2023 | 6.37 Mn |
| Jun 30, 2023 | 24.70 Mn |
| Mar 31, 2023 | 10.77 Mn |
| Dec 31, 2022 | 6.26 Mn |
| Sep 30, 2022 | 7.05 Mn |
| Jun 30, 2022 | 8.12 Mn |
| Mar 31, 2022 | 10.05 Mn |
| Dec 31, 2021 | 4.37 Mn |
API Access
Amylyx Pharmaceuticals Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=AMLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "AMLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=AMLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();